- 0
- 207 words
November 20, 2026 / 3:37 PM EST / CBS News
\n\nFresh off its record-setting initial public offering, Anthropic now must show investors that it can sustain growth and generate profits. The company has a plan for that: curing some of the world's gnarliest diseases.
\n\nIn its IPO prospectus, Anthropic states that AI holds the potential to "profoundly accelerate the rate of progress in biology and medicine, potentially curing diseases that have plagued humanity for millennia, including cancer, Alzheimer's disease, heart disease, rare genetic diseases, and the major infectious diseases."
\n\nAnthropic co-founder and CEO Dario Amodei said in a post on X in August that he believes "it will actually be possible to cure most human disease in ~5-10 years, as crazy as it may sound to ordinary people and frankly to biologists as well (I used to be one!)."
\n\nDeveloping breakthrough drugs is among the most promising avenues of research for AI, potentially bringing treatments for a range of conditions to market much faster than is currently possible, according to scientists and industry analysts.
\n\n"AI can accelerate research. It will help you get there faster, but it's not just speed — it's directional speed," Neerav Kaushal, an AI and molecular…
Original source: https://www.cbsnews.com/moneywatch/
